CD133 is a membrane glycoprotein expressed in cancer stem cells [23], and recent results reveal its prognostic role in a spectrum of solid tumors such as lung [24], glioma [25], and ovarian [26] cancers. Here, PROM1 is linked to central nervous system cancer.